NCT00370799

Brief Summary

To demonstrate clinically significant improvements or lack thereof in the caudal epidural patients with our without steroids. To evaluate differences in outcomes in patients receiving steroids compared to those patients randomized to the local anesthetic group who did not receive steroids. To assess improvements among patients and compare steroid groups with each other and local anesthetic group. To evaluate and compare the adverse event profile in all patients

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for early_phase_1

Timeline
Completed

Started Jan 2007

Typical duration for early_phase_1

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 30, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 1, 2006

Completed
4 months until next milestone

Study Start

First participant enrolled

January 1, 2007

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2009

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2010

Completed
Last Updated

August 16, 2013

Status Verified

August 1, 2013

Enrollment Period

2.9 years

First QC Date

August 30, 2006

Last Update Submit

August 14, 2013

Conditions

Keywords

Caudal Epidural injectionslumbar disc herniationspinal stenosisdiscogenic painpost-lumbar laminectomy syndrome

Outcome Measures

Primary Outcomes (1)

  • To evaluate for differences between the patients in various groups in the physical function and pain at 1, 3, 6, and 12 months post treatment

    1,3,6,12 months

Secondary Outcomes (1)

  • To assess adverse events in all four groups.

    1,3,6,12 months

Study Arms (4)

local anesthetic

ACTIVE COMPARATOR

Group 1. local anesthetics only

Drug: Caudal epidural injection

Local anesthetic with generic Celestone

ACTIVE COMPARATOR

Group 2. local anesthetic with 6mg of non-particulate Celestone

Drug: Caudal Epidural Injection with generic Celestone

Local anesthetic with Celestone

ACTIVE COMPARATOR

Group 3. local anesthetic with 6 mg of brand nameCelestone

Drug: Caudal Epidural Injection with Celestone

Local anesthetic with DepoMedrol

ACTIVE COMPARATOR

Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol

Drug: Caudal Epidural Injection with DepoMedrol

Interventions

group 1: Caudal epidural injection local anesthetics only

Also known as: Group 1
local anesthetic

Group 2. Caudal Epidural Injection local anesthetic with 6mg of non-particulate Celestone

Also known as: Group 2
Local anesthetic with generic Celestone

Group 3. Caudal Epidural Injection with local anesthetic with 6 mg of brand name Celestone

Also known as: Group 3
Local anesthetic with Celestone

Group 4. local anesthetic with 40 mg of alcohol-free DepoMedrol

Also known as: Group 4
Local anesthetic with DepoMedrol

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • At least 18 years of age
  • History of chronic, function-limiting low back pain of at least 6 months duration
  • Able to give voluntary, written informed consent to participate,
  • Able to understand the investigation, cooperate with the procedures, and willing to return for follow-up
  • No recent surgical procedures within last three months

You may not qualify if:

  • Cauda Equina symptoms and/or compressive radiculopathy
  • Narcotic use of no greater than 100mg/day hydrocodone, 60mg Methadone. or 100mg morphine
  • Uncontrolled major Depression or uncontrolled psychiatric disorder
  • Uncontrolled or acute medical illnesses
  • Chronic severe conditions that could interfere with outcome assessments
  • Women who are pregnant or lactating
  • Subjects who have participated in a clinical study with an investigational product within 30 days of enrollment
  • Patients with multiple complaints involving concomitant hip osteoarthritis
  • Inability to achieve proper positioning and inability to understand informed consent and protocol
  • History of adverse reaction to local anesthetic or anti-inflammatory drugs and history of gastrointestinal bleeding or ulcers

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ambulatory Surgery Center

Paducah, Kentucky, 42001, United States

Location

Related Publications (3)

  • Manchikanti L, Singh V, Cash KA, Pampati V, Damron KS, Boswell MV. Effect of fluoroscopically guided caudal epidural steroid or local anesthetic injections in the treatment of lumbar disc herniation and radiculitis: a randomized, controlled, double blind trial with a two-year follow-up. Pain Physician. 2012 Jul-Aug;15(4):273-86.

  • Manchikanti L, Cash KA, McManus CD, Pampati V, Smith HS. One-year results of a randomized, double-blind, active controlled trial of fluoroscopic caudal epidural injections with or without steroids in managing chronic discogenic low back pain without disc herniation or radiculitis. Pain Physician. 2011 Jan-Feb;14(1):25-36.

  • Manchikanti L, Singh V, Cash KA, Pampati V, Datta S. Management of pain of post lumbar surgery syndrome: one-year results of a randomized, double-blind, active controlled trial of fluoroscopic caudal epidural injections. Pain Physician. 2010 Nov-Dec;13(6):509-21.

MeSH Terms

Conditions

Low Back PainIntervertebral Disc DisplacementSpinal Stenosis

Interventions

Betamethasone

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, Anatomical

Intervention Hierarchy (Ancestors)

PregnadienetriolsPregnadienesPregnanesSteroidsFused-Ring CompoundsPolycyclic CompoundsSteroids, Fluorinated

Study Officials

  • Laxmaiah Manchikanti, MD

    Ambulatory Surgery Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
early phase 1
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Medical Director

Study Record Dates

First Submitted

August 30, 2006

First Posted

September 1, 2006

Study Start

January 1, 2007

Primary Completion

December 1, 2009

Study Completion

March 1, 2010

Last Updated

August 16, 2013

Record last verified: 2013-08

Locations